max dose retatrutide Dosing Schedule: From Clinical Trials to Real Weight Loss Outcomes Retatrutide in adults with obesity

In oncology, Bristol Myers Squibbs iberdomide and mezigdomide aim to replace older myeloma therapies with next-generation oral CELMoDs

Semaglutide (Wegovy, Ozempic) aims at one receptor (GLP-1), while tirzepatide (Zepbound, Mounjaro) homes in on two (GLP-1 and GIP)

It is the foundation of several breakthrough medications that are revolutionizing the treatment of obesity and type 2 diabetes

International Journal of Obesity , 33(9), 956961

Research Overview Retatrutide is a next-generation multi-agonist peptide that engages GIP, GLP-1 and glucagon receptors simultaneously

Nader admitted to "microdosing" GLP-1s (taking less than the dosage ordinarily prescribed), but said she wouldn't stop, claiming that she was under too much pressure to stay lean